Relative efficacy of <scp>GLP</scp> ‐1 and <scp>GLP</scp> ‐1/ <scp>GIP</scp> receptor agonists in the prevention of alcohol‐use disorders using a target trial emulation approach
In patients with T2D, tirzepatide and semaglutide treatment is associated with a lower incidence of AUD; robust randomised, controlled evidence for the use of these drugs for this novel indication is appropriate.
Authors
- David R. J. Riley (ORCID: https://orcid.org/0000-0002-0905-6524)
- Uazman Alam (ORCID: https://orcid.org/0000-0002-3190-1122)
- Carl Roberts (ORCID: https://orcid.org/0000-0003-4275-601X)
- Theresa Hydes (ORCID: https://orcid.org/0000-0002-7768-6886)
- Alex E. Henney (ORCID: https://orcid.org/0000-0002-8066-9470)
- Daniel James Cuthbertson (ORCID: https://orcid.org/0000-0002-6128-0822)
- David M. Hughes (ORCID: https://orcid.org/0000-0002-1287-9994)
- Matthew Anson (ORCID: https://orcid.org/0000-0001-9991-7369)
- Megan Heague (ORCID: https://orcid.org/0009-0005-1419-1324)
Institutions
- University of Liverpool (GB)
- Aintree University Hospitals NHS Foundation Trust (GB)
- Merseytravel (GB)
- Liverpool Womens NHS Foundation Trust (GB)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-10-07
- DOI
- https://doi.org/10.1111/dom.70169
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.59